Q3 2025: Positives beyond the headline
19/08/25 -"Coloplast reported Q3 2025 organic growth of 7%, driven by broad-based growth. EBIT before special items edged up 2% to DKK 1.915 billion, with a healthy 28% margin, but net profit dropped 14.6% due ..."
Pages
60
Language
English
Published on
19/08/25
You may also be interested by these reports :
21/08/25
GN’s Q2 performance surpassed market expectations. Although top-line growth was constrained by an uncertain macroeconomic environment, profitability ...
20/08/25
The Q2 results fell short of expectations and, consequently, the management downgraded its guidance for the second time this year. A subdued market ...
19/08/25
Coloplast reported Q3 2025 organic growth of 7%, driven by broad-based growth. EBIT before special items edged up 2% to DKK 1.915 billion, with a ...
13/08/25
Demant’s Q2 sales underperformed expectations, with top-line growth remaining flat. Growth in Hearing Care was offset by a decline in Diagnostics. ...